STOCK TITAN
  1. Home
  2. IQMDU

Intelligent Medicine Acquisition Stock Price, News & Analysis

IQMDU NASDAQ

Company Description

Intelligent Medicine Acquisition (NASDAQ: IQMDU) is a publicly traded company.

IQMDU stock has gained 8.7% over the past year.

This page provides a comprehensive overview of IQMDU stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
+8.71%
Performance 1 year
$0.0
Market Cap
20.7M
Shares outstanding

Intelligent Medicine Acquisition (IQMDU) stock. Over the past 12 months, the stock has gained 8.7%.

Latest News

View All
+0.01%

Kroll Appoints Patience Marime-Ball as Senior Advisor to Kroll’s ESG Advisory Services

management
+0.01%

Kroll Appoints Patience Marime-Ball as Senior Advisor to Kroll’s ESG Advisory Services Committee

management
+0.05%

Intelligent Medicine Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing December 27, 2021

acquisition
+0.39%

Intelligent Medicine Acquisition Corp. Announces Closing of Upsized $207,000,000 Initial Public Offering

IPO offering acquisition
—

Intelligent Medicine Acquisition Corp. Announces Pricing of Upsized $180,000,000 Initial Public Offering

IPO offering acquisition

Intelligent Medicine Acquisition has 5 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 0 with negative movement. Key topics include management, acquisition, IPO, offering. View all IQMDU news →

SEC Filings

View All

No SEC filings available for IQMDU.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months